Clinical Trials
80 trialsProximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer
Nanchong Central Hospital
Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy
Nanchong Central Hospital
SIEWERT-RCT
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Surgery for Obstructed Gastric Carcinoma
Zagazig University
Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer
Henan Cancer Hospital
Co-SNARE
Region Stockholm
Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions
Nizhny Novgorod Regional Clinical Oncology Center
Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer
Henan Cancer Hospital
TLPG-CBVP
Fujian Cancer Hospital
A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors
Fujian Cancer Hospital
LE-RACUS
Region Stockholm
Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
Fujian Cancer Hospital
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
Shanghai Public Health Clinical Center
Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.
Azienda USL Reggio Emilia - IRCCS
JAGC1
Nizhny Novgorod Regional Clinical Oncology Center
Effect of Smart Phone App-based Human Coaching Program in Gastrectomized Patients
National Cancer Center, Korea
SENORITA2
National Cancer Center, Korea
Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab
Fujian Cancer Hospital
HELPER
National Cancer Center, Korea
EASTERN
National Cancer Center, Korea
ERASE-GC
National Cancer Center, Korea
Anastomotic Leak Testing in Gastrectomy
Nanchong Central Hospital
Effect of High Protein ONS on Older Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy
Erzincan Binali Yildirim University Mengucek Gazi Training and Research Hospital
TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma
Henan Cancer Hospital
SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma
Henan Cancer Hospital
Complete Mesogastric Excision With D2 Lympadenectomy for Gastric Cancer:
Başakşehir Çam & Sakura City Hospital
Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients.
Shandong Provincial Hospital
Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression
Henan Cancer Hospital
Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer
Fujian Cancer Hospital
Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication
National Cancer Center, Korea
Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD
National Cancer Center, Korea
PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors
Fujian Cancer Hospital
Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition
Hospital Galdakao-Usansolo
Tranexamic Acid During Upper GI Endoscopic Resection Procedures
Assaf-Harofeh Medical Center
Feasibility Study of Sentinel Navigation Surgery in Early Gastric Cancer Using Fluorescence (SENORITA4)
National Cancer Center, Korea
Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancer
Fujian Cancer Hospital
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer
Sheba Medical Center
CKD-702 Plus Irinotecan in Gastric Cancer
National Cancer Center, Korea
Vactosertib and Durvalumab in Gastric Cancer
National Cancer Center, Korea
Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes
Henan Cancer Hospital
A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies
Sheba Medical Center
Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy
National Cancer Center, Korea
Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma
Henan Cancer Hospital
Effectiveness of Exercise Program in Improving Quality of Life in Patients With Gastric Cancer Undergoing Gastrectomy
Taipei Veterans General Hospital, Taiwan
Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)
National Cancer Center, Korea
POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC
Fujian Cancer Hospital
SCAR
National Healthcare Group, Singapore
GI-ACP
NHS Lothian
A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer
Henan Cancer Hospital
Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer
National Cancer Center, Korea